Zealand Pharma conference call on May 7 at 2pm CET (8am ET) to present first quarter 2026 financial results

About this update from Zealand Pharma A/s

[{"type":"image","alt":"Zealand Pharma","displaySize":"","headline":null,"caption":"Zealand Pharma","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":121,"url":"https://media.zenfs.com/en/globenewswire.com/2567d307984f8639b4a7711f51c64eff"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/hruCjDK29WWlg5.YGk148A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE2OQ--/https://media.zenfs.com/en/globenewswire.com/2567d307984f8639b4a7711f51c64eff","width":300,"height":121}},"lazy":false},{"type":"text","content":"Press Release – No. 8 / 2026","length":28,"tagName":"p"},{"type":"text","content":"Zealand Pharma conference call on May 7 at 2pm CET (8am ET) to present first quarter 2026 financial results","length":107,"tagName":"p"},{"type":"text","content":"Copenhagen, Denmark and Boston, Massachusetts, April 30, 2026 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future of metabolic health, announced that it will host a conference call on May 7, 2026, at 2:00 pm CET (8:00 am ET) following the announcement of financial results for the first quarter / first three months of 2026.","length":386,"tagName":"p"},{"type":"text","content":"Participating in the call will be President and Chief Executive Officer, Adam Steensberg; Chief Financial Officer, Henriette Wennicke; and Chief Medical Officer, David Kendall. The presentation will be followed by a Q&A session.","length":232,"tagName":"p"},{"type":"text","content":"To receive telephone dial-in information and a unique personal access PIN, please register at Conference Registration. The live listen-only audio webcast of the call and accompanying slides presentation will be accessible at Zealand Pharma results for Q1 2026. Participants are advised to register for the call or webcast approximately 10 minutes before the start. A recording of the event will be available following the call on the Investor section of Zealand Pharma’s website at https://www.zealandpharma.com/events/.","length":520,"tagName":"p"},{"type":"text","content":"About Zealand Pharma A/S","length":24,"tagName":"p"},{"type":"text","content":"Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on advancing medicines for obesity and metabolic health. Combining more than 25 years of peptide R&D expertise with a proprietary data platform that lever...

More updates from Zealand Pharma A/s